Are There Risks Associated with Targeting Death Receptors?
While targeting death receptors holds therapeutic promise, there are risks associated with such interventions. Non-selective activation of death receptors can lead to off-target effects and damage to normal tissues. Additionally, the redundancy and complexity of apoptotic pathways can result in unpredictable responses, necessitating careful consideration of therapeutic windows and combination therapies to enhance specificity and minimize adverse effects.
